Status UnknownBusiness
Biomedical Translation Fund – Investee Companies
Australian Government · Australia
This page lists companies that have received investment commitments from the Biomedical Translation Fund (BTF) to advance biomedical discoveries and commercialise new medical technologies and therapies.
Funding
Up to $43.9M
Location
Australia
Who Can Apply
Eligibility details are not provided on this investee companies page.
The listed organisations are biomedical and health-related companies developing innovative therapies, devices, or technologies.
Formal criteria for new applicants must be obtained from the main Biomedical Translation Fund program information.
The source content only provides a list of companies that have already received investment commitments from the Biomedical Translation Fund (BTF) and brief descriptions of their projects. It does not describe the formal eligibility criteria for new applicants, such as required entity types, location, stage of development, or specific financial or technical requirements. Therefore, detailed eligibility criteria for prospective applicants cannot be determined from this page alone.
What's Funded
Development and clinical translation of biomedical technologies, including medical devices, novel therapeutics, neuromodulation technologies, digital health and monitoring systems, drug formulations, vaccines, and other health-related innovations aimed at treating or managing diseases and conditions.Before you apply
Check Biomedical Translation Fund – Investee Companies fit and evidence gaps
Use this business grant page to sanity-check eligibility, funding fit, evidence gaps and application effort before you commit days to drafting. If you already know the grant you want, the 48-hour audit gives a practical go/no-go view, reviewer-readiness score and next-step risks.
Get a 48-hour grant fit auditExpected Outcomes
Commercially viable biomedical products and therapies such as approved medical devices, drugs, vaccines, and digital health solutions that improve diagnosis, treatment, and management of diseases and conditions, and progress through clinical trials and regulatory pathways.Key Information
Funding Purposes
r_and_dinnovationcommercialisationresearch
Keywords
Biomedical Translation FundBTFbiomedicalmedical devicestherapeuticsclinical trialshealth technologycommercialisation
Frequently Asked Questions
1
What is the Biomedical Translation Fund – Investee Companies?
The Biomedical Translation Fund – Investee Companies is a business grant offered by Australian Government in Australia, providing Up to $43.9M in funding. This page lists companies that have received investment commitments from the Biomedical Translation Fund (BTF) to advance biomedical discoveries and commercialise new medical technologies and therapies.
2
How much funding does the Biomedical Translation Fund – Investee Companies provide?
The Biomedical Translation Fund – Investee Companies provides Up to $43.9M in funding.
3
Who is eligible for the Biomedical Translation Fund – Investee Companies?
Eligibility details are not provided on this investee companies page.
The listed organisations are biomedical and health-related companies developing innovative therapies, devices, or technologies.
Formal criteria for new applicants must be obtained from the main Biomedical Translation Fund program information.
4
What activities are funded?
Development and clinical translation of biomedical technologies, including medical devices, novel therapeutics, neuromodulation technologies, digital health and monitoring systems, drug formulations, vaccines, and other health-related innovations aimed at treating or managing diseases and conditions.
5
How do I apply for the Biomedical Translation Fund – Investee Companies?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.